Investigator identification

Investigator identification

Investigator identification

Discover the experts who drive trusted results.

TA Scan’s unbiased scoring system maps investigators across every therapeutic area, helping you select the right principal investigators (PIs) or key opinion leaders (KOLs).

Engage experts who perform

Score candidates on real-world expertise and activity

Go beyond one-and-done PIs

Filter out low-activity of high-turnover profiles

Expand your pool

 Uncover emerging talent before competitors do

The problem

Investigator turnover is high, and many PIs are “one-and-done.” Without visibility into true experience, expertise, and patient access, teams risk selecting investigators who can’t deliver.

The solution

Prioritize partners who have the capacity and relevance to your study. TA Scan unifies trial activity, scientific expertise, and real-world patient insights (US) into complete investigator profiles — helping you prioritize partners who have the capacity, track record, and relevance to your study.

WHAT YOU CAN DO

Discover investigator who deliver

WHAT YOU CAN DO

Discover investigator who deliver

WHAT YOU CAN DO

Discover investigator who deliver

Granular Investigator Search

Filter by therapeutic area, rare disease, line of therapy, age/sex sub-population, geography, and more.

Granular Investigator Search

Filter by therapeutic area, rare disease, line of therapy, age/sex sub-population, geography, and more.

Granular Investigator Search

Filter by therapeutic area, rare disease, line of therapy, age/sex sub-population, geography, and more.

Proprietary Investigator Scoring & Rankings

Evaluate investigators based on trial activity, publications, presentations, and network influence.

Proprietary Investigator Scoring & Rankings

Evaluate investigators based on trial activity, publications, presentations, and network influence.

Proprietary Investigator Scoring & Rankings

Evaluate investigators based on trial activity, publications, presentations, and network influence.

Collaboration & Network Mapping

Uncover who works together, and identify institutional ecosystems.

Collaboration & Network Mapping

Uncover who works together, and identify institutional ecosystems.

Collaboration & Network Mapping

Uncover who works together, and identify institutional ecosystems.

Diversity & Demographic Insights (Global)

Understand investigator access to diverse patient populations to support diversity and inclusion goals.

Diversity & Demographic Insights (Global)

Understand investigator access to diverse patient populations to support diversity and inclusion goals.

Diversity & Demographic Insights (Global)

Understand investigator access to diverse patient populations to support diversity and inclusion goals.

Activity and Potential Monitoring

Differentiate consistently active investigators from idle or low-engagement profiles, or surface rising stars in niche therapeutic areas.

Activity and Potential Monitoring

Differentiate consistently active investigators from idle or low-engagement profiles, or surface rising stars in niche therapeutic areas.

Activity and Potential Monitoring

Differentiate consistently active investigators from idle or low-engagement profiles, or surface rising stars in niche therapeutic areas.

Strategic Support Included

Our team helps refine investigator criteria and shortlist logic — no additional service fees.

Strategic Support Included

Our team helps refine investigator criteria and shortlist logic — no additional service fees.

Strategic Support Included

Our team helps refine investigator criteria and shortlist logic — no additional service fees.

industries

Choose TA Scan over your
standard data providers

industries

Choose TA Scan over your
standard data providers

industries

Choose TA Scan over your
standard data providers

TA Scan

Your standard provider

Unified investigator profiles from multiple sources

Clinical AND scientific footprint (trial participation + publications + conference presentations)

Activity over time (consistency, recency, momentum)

Transparent scoring & prioritization (objective, repeatable)

Competitive and engagement insights (advanced analytics for sponsor relationships, fee disclosures)

Patient access (US) & diversity indication (global)

TA Scan

Your standard provider

Unified investigator profiles from multiple sources

Clinical AND scientific footprint (trial participation + publications + conference presentations)

Activity over time (consistency, recency, momentum)

Transparent scoring & prioritization (objective, repeatable)

Competitive and engagement insights (advanced analytics for sponsor relationships, fee disclosures)

Patient access (US) & diversity indication (global)

TA Scan

Your standard provider

Unified investigator profiles from multiple sources

Clinical AND scientific footprint (trial participation + publications + conference presentations)

Activity over time (consistency, recency, momentum)

Transparent scoring & prioritization (objective, repeatable)

Competitive and engagement insights (advanced analytics for sponsor relationships, fee disclosures)

Patient access (US) & diversity indication (global)

More high-performing investigators identified per study

Expand beyond historical rosters with comprehensive global coverage.

-40%

Reduction in time spent evaluating investigator fit

Unbiased scoring accelerates the shortlist process.

2.5M+

Investigator and HCP profiles globally

Find qualified investigators in any indication or geography.

How it works

How investigator identification works

How it works

How investigator identification works

How it works

How investigator identification works

Search the Investigator Landscape

Identify all investigators active in your indication, geography, and target populations

Experience it for free

Evaluate Experience

Benchmark trial history, scientific expertise, and consistency of activity over time.

Experience it Live

One-and-Done Profiles

Quickly eliminate investigators with low or inconsistent engagement to reduce delivery risk.

Experience it for free

Analyze Networks & Influence

See collaboration patterns, institutional clusters, and emerging investigators.

Experience it for free

Prioritize & Plan Engagement

Generate ranked shortlists aligned to study needs, diversity goals, and capacity.

Experience it for free

“Because of TA Scan, we decreased the time it takes for that initial vetting of our sites, gaining an efficiency advantage in clinical operations”

Top 10 pharma company

“Because of TA Scan, we decreased the time it takes for that initial vetting of our sites, gaining an efficiency advantage in clinical operations”

Position

“Because of TA Scan, we decreased the time it takes for that initial vetting of our sites, gaining an efficiency advantage in clinical operations”

Position

Who we work with

Explore how TA Scan solves challenges across the industry

Who we work with

Explore how TA Scan solves challenges across the industry

Who we work with

Explore how TA Scan solves challenges across the industry

ADDITIONAL Resources

Learn more about TA Scan investigator-identification

ADDITIONAL Resources

Learn more about TA Scan investigator-identification

ADDITIONAL Resources

Learn more about TA Scan investigator-identification

Man holding a Clinical insights note

Competitive insights

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

As we approach mid 2025, the clinical research landscape reflects resilience, innovation, and global rebalancing.

Elke Ydens

Associate Director of Business Solutions

Competitive insights

Man holding a Clinical insights note

Competitive insights

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

As we approach mid 2025, the clinical research landscape reflects resilience, innovation, and global rebalancing.

Elke Ydens

Associate Director of Business Solutions

Competitive insights

Man holding a Clinical insights note

Competitive insights

Mid-Year 2025 Clinical Trial Wrap – TA Scan Edition

As we approach mid 2025, the clinical research landscape reflects resilience, innovation, and global rebalancing.

Elke Ydens

Associate Director of Business Solutions

Competitive insights

people working

Clinical insights

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Explore how our security-first approach keeps your financial data safe and your mind at ease.

Elke Ydens

Associate Director of Business Solutions

Clinical insights

people working

Clinical insights

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Explore how our security-first approach keeps your financial data safe and your mind at ease.

Elke Ydens

Associate Director of Business Solutions

Clinical insights

people working

Clinical insights

Revolutionizing Clinical Trial Feasibility: TA Scan’s Trial Feasibility Flex

Explore how our security-first approach keeps your financial data safe and your mind at ease.

Elke Ydens

Associate Director of Business Solutions

Clinical insights

hand with device working

Competitive insights

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Elke Ydens

Associate Director of Business Solutions

Competitive insights

hand with device working

Competitive insights

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Elke Ydens

Associate Director of Business Solutions

Competitive insights

hand with device working

Competitive insights

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Enrollment Benchmarking: Driving Predictability in Clinical Trial Timelines

Elke Ydens

Associate Director of Business Solutions

Competitive insights